A recap of social media updates from the 33rd Annual Meeting of the Society for Maternal and Fetal Medicine. #SMFM13
The 33rd Annual Meeting of the Society for Maternal-Fetal Medicine (SMFM) recently concluded in San Francisco. At the conference, world-renowned leaders in maternal-fetal medicine presented cutting-edge basic, clinical and epidemiological research. Here we highlight top tweets from the meeting, including coverage of an award presented to Contemporary OB/GYN Editorial Board member Elliott Main, MD.
[
View the story "#SMFM13" on Storify
]
Storified by ContemporaryOBGYN· Tue, Feb 19 2013 13:02:26
Study links periconceptual folic acid with reduced autism risk http://fb.me/J8EFgzvTMy SMFMDr Veyver (Baylor): NIPT is appropriate for detecting aneuploidies in high risk women #SMFM13Gautam KolluDr Norton (Stanford): Disproportionate number of positives in 'no call' zone for Verinata's test $ILMN #SMFM13Gautam Kollu"As you can see, our country is covered in pessaries." Great line from ProTWIN study presentation. #smfm13Wash U ObGyn3 of first 8 oral presentations dealing with short cervix. Decidedly international flair as well. #smfm13Wash U ObGyn5 year follow up of MACS trial: no difference in death, growth or neurodevelopment after multiple courses of antenatal steroids. #smfm13My SMFM17OHP is ineffective in asymptomatic twins with a short cervix (<25 mm) #smfm13Wash U ObGynMichael Foley wins SMFM Lifetime Achievement Award. #smfm13My SMFMBetween 17OHP study today, in addition to knowledge about Rouse, there is lack of evidence of benefit in twin pregnancies. #smfm13Wash U ObGynAs far as steroids, one course good. Rescue good (Garite). Multiple have potential for harm and now no long term benefit. #smfm13Wash U ObGynCell free fetal RNA in amniotic fluid of obese women reveal a proestrogenic, pro inflammatory state. #smfm13Wash U ObGynHighly encouraged by the huge collaborations being presented today #smfm13. Twin birth study with 2800 women from 26 countries!Wash U ObGynRCT of planned mode of delivery for twins: 4% of planned vag needed CS, no difference in maternal or perinatal outcome. #smfm13My SMFMOur fellow Amanda Trudell presenting her work on risk of still birth after 37 weeks. #smfm13 http://pic.twitter.com/TeHBSGEBWash U ObGynRCT of DHA- and EPA-rich fish oil for women at risk for postpartum depression: no benefit. #smfm13My SMFMHeather Frey presenting her study on Genetic Variation associated with Preterm Birth in Black Women. #smfm13 http://pic.twitter.com/BODZDKfXWash U ObGynIndira Mysorekar and her presentation of bacterial reservoirs. #smfm13 http://pic.twitter.com/CoPFv96mWash U ObGynDr. Platt leading the Pregnancy Foundation @ThePregFound with initiation of the Quilligan Scholars Program. #smfm13 http://pic.twitter.com/JkD8rOxUMy SMFM@MySMFM Dr. Quilligan and Dr. Zuspan. 2 giants in the field of MFM. They have changed many lives. #smfm13 http://pic.twitter.com/WplJoKsIMy SMFMVery interesting. @SRomAndARom: Allergic disorders more common among children born by cesarean section, exposed to Western diet #SMFM13âWash U ObGynDecreased brain apoptosis seen in fetuses of obese pregnant women. Study evaluated cffDNA in amniotic fluid specimens. #smfm13Wash U ObGynEdlow et al: maternal obesity associated with differential expression of genes involved in neurodevelopment. #smfm13My SMFMHalf of reproductive-aged women with OSA and symptoms had mod-severe echo findings. #smfm13My SMFMNicotine exposure in utero associates with increased risk of cardiovascular disease in female offspring. #smfm13My SMFMGyamfi: diabetes not independently associated with RDS in preterm infants #smfm13My SMFMNeat to see social media studies at #smfm13. This looked at SM usage in Boston. http://pic.twitter.com/k00YBVBXWash U ObGynGetting ready for some late breaking research added to conference. #smfm13. #aspirin http://pic.twitter.com/bovVTHcLWash U ObGyn11 NNT with low dose ASA to achieve live birth in restricted stratum (single loss within 12 months). Need to start preconception. #smfm13Wash U ObGynLow dose aspirin improves live birth rate in women with a pregnancy loss within year prior to conception. #smfm13My SMFMTaking low dose ASA prior to conception improves live birth of one had a miscarriage prior to 20 weeks. #smfm13My SMFMHealthy Moms trial: lifestyle intervention with weekly group support reduces gestational weight gain and LGA births in obese women. #smfm13My SMFM#smfm13 Dr Lu and MCHB part of newly launched National Strategy to reduce Infant Mortality w March of Dimes, Strong Start and more.CMQCC#smfm13 Dr Lu. #SACIM works to move US infant mortality below 4.5. First on list - Improve Womens Health before during beyond pregnancy!CMQCCGreat group of MFMs at R&G. #smfm13 http://pic.twitter.com/xeq7t8KPAnthony Shanks#smfm13 CMQCC preeclampsia task force co-chair Dr Larry Shields research award - OB hemorrhage protocols work! http://pic.twitter.com/xItvqbdbCMQCC#smfm13 Congratulations Drs Elliott Main and Larry Shields! Peer recognition of your contribution to maternal health http://pic.twitter.com/QNyibRR4CMQCCUNC's Dr. Menard | Aspirin May Up Chance for Baby After Miscarriage http://bit.ly/12E3jQz @MySMFM #smfm13UNC OBGYNTwins Don't Need C-Sections http://nyti.ms/Zp7LBP (but you'd want an MD who is experienced w/vaginal breech deliveries) #smfm13Ruth Ann Crystal, MD
Reduced subsequent births reported after severe maternal morbidity
November 26th 2024Women experiencing severe maternal morbidity during their first pregnancy face significantly lower odds of subsequent births, emphasizing the need for personalized reproductive counseling and ongoing monitoring.
Read More
Maternal sFLT1 and EDN1 linked to late-onset preeclampsia
November 25th 2024A new study highlights the association of maternal soluble Fms-like tyrosine kinase 1 and endothelin 1 with preeclampsia severity, offering insights into the pathogenesis of early- and late-onset forms of the condition.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Reduced subsequent births reported after severe maternal morbidity
November 26th 2024Women experiencing severe maternal morbidity during their first pregnancy face significantly lower odds of subsequent births, emphasizing the need for personalized reproductive counseling and ongoing monitoring.
Read More
Maternal sFLT1 and EDN1 linked to late-onset preeclampsia
November 25th 2024A new study highlights the association of maternal soluble Fms-like tyrosine kinase 1 and endothelin 1 with preeclampsia severity, offering insights into the pathogenesis of early- and late-onset forms of the condition.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
2 Commerce Drive
Cranbury, NJ 08512